New ASTRO guideline endorses hypofractionated radiation across prostate cancer risk groups

Guideline · CancerNetwork · 2026-10-28. Number 1 in the UrologyWatch Top 5 for October 29, 2026.

ASTRO has issued an updated guideline supporting use of hypofractionated radiation therapy regimens across risk groups in localized prostate cancer.

Why it matters: A new society guideline on radiation fractionation could influence treatment planning discussions and referral patterns for localized prostate cancer.

Source: CancerNetwork

The full October 29, 2026 edition · Today's urology news